GSC
ISEE

Ground Swell Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Ground Swell Capital’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-126
Closed -$5K – 2855
2014
Q2 		$5K Buy
+126
New +$4.62K 0.01% 1111

Other funds holding ISEE

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ground Swell Capital's ISEE Position: Q3 2014 in Review

Ground Swell Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2014, closing a stake of 126 shares — an estimated $5K sold.

Ground Swell Capital first reported a position in ISEE in Q2 2014 and held it in 1 quarter. The position peaked at $5K in Q2 2014. 92 funds tracked by Wall St. Rank hold ISEE as of Q3 2014.

  • Ground Swell Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Ground Swell Capital sold 126 IVERIC bio, Inc. Common Stock shares in Q3 2014, an estimated $5K.
  • Ground Swell Capital first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 1 quarter.
  • Ground Swell Capital's IVERIC bio, Inc. Common Stock position peaked at $5K in Q2 2014.
  • 92 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.